Concepedia

Paul R. Keller

PR

45

Publications

3.8K

Citations

24

H-Index

1981

Active since

Affiliations

University of Tennessee at Knoxville(Current)

University of Wisconsin–Madison

Oak Ridge National Laboratory

Pfizer (United States)

University of Michigan

Paul R. Keller is an author at University of Tennessee at Knoxville specializing in natural sciences, chemistry, and engineering.

Top concepts

Publications per year

1981–2015

45

Publications

45

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

David W. Fry, Patricia J. Harvey, Paul R. Keller et al. · Molecular Cancer Therapeutics · 2004 · 1.2K citations

Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6

Peter L. Toogood, Patricia J. Harvey, Joseph T. Repine et al. · Journal of Medicinal Chemistry · 2005 · 498 citations · Full text

, , +19

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

David W. Fry, Alexander J. Bridges, William A. Denny et al. · Proceedings of the National Academy of Sciences · 1998 · 417 citations

, , +21

Assessment of Screening for Prostate Cancer Using the Digital Rectal Examination

Gerald W. Chodak, Paul R. Keller, Harry W. Schoenberg · The Journal of Urology · 1989 · 179 citations

Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Scott N. VanderWel, Patricia J. Harvey, Dennis J. McNamara et al. · Journal of Medicinal Chemistry · 2005 · 148 citations · Full text

, , +14

Rows per page

1–5 of 45